Stephen Willey
Stock Analyst at Stifel
(3.91)
# 626
Out of 5,054 analysts
123
Total ratings
44.44%
Success rate
12.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Reinstates: Buy | $125 | $84.18 | +48.49% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $89.50 | +44.13% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $108.04 | +6.44% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.51 | +156.78% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $189.43 | -23.45% | 8 | Aug 14, 2025 | |
| NKTX Nkarta | Maintains: Buy | $14 → $12 | $2.00 | +501.50% | 4 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.93 | +78.12% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $42.02 | -2.43% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $77.07 | -61.07% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $13.12 | +113.41% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.47 | +240.14% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $4.81 | +315.80% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $13.10 | +167.18% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $9.98 | +902.00% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.21 | +231.95% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $18.87 | +48.38% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $14.38 | +226.84% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.69 | +483.90% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.66 | +140.96% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $38.52 | +60.96% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.41 | +104.31% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.53 | +686.89% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.01 | +14,228.36% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.59 | +710.81% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.49 | +168.46% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $447.09 | -72.49% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $71.57 | -34.33% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $54.28 | +100.81% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $21.36 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $9.21 | +149.73% | 5 | Feb 7, 2018 |
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $84.18
Upside: +48.49%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $89.50
Upside: +44.13%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $108.04
Upside: +6.44%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.51
Upside: +156.78%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $189.43
Upside: -23.45%
Nkarta
Aug 14, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.00
Upside: +501.50%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.93
Upside: +78.12%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $42.02
Upside: -2.43%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $77.07
Upside: -61.07%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $13.12
Upside: +113.41%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.47
Upside: +240.14%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $4.81
Upside: +315.80%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $13.10
Upside: +167.18%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $9.98
Upside: +902.00%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.21
Upside: +231.95%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $18.87
Upside: +48.38%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $14.38
Upside: +226.84%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.69
Upside: +483.90%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.66
Upside: +140.96%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $38.52
Upside: +60.96%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $4.41
Upside: +104.31%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.53
Upside: +686.89%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.01
Upside: +14,228.36%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.59
Upside: +710.81%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.49
Upside: +168.46%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $447.09
Upside: -72.49%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $71.57
Upside: -34.33%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $54.28
Upside: +100.81%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $21.36
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $9.21
Upside: +149.73%